These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25070109)

  • 21. In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation.
    Kiara SM; Okombo J; Masseno V; Mwai L; Ochola I; Borrmann S; Nzila A
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3793-8. PubMed ID: 19528269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine.
    Madamet M; Briolant S; Amalvict R; Benoit N; Bouchiba H; Cren J; Pradines B;
    Parasit Vectors; 2016 Feb; 9():77. PubMed ID: 26858119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
    Ochola-Oyier LI; Okombo J; Mwai L; Kiara SM; Pole L; Tetteh KK; Nzila A; Marsh K
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1770-5. PubMed ID: 25534732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.
    Folarin OA; Bustamante C; Gbotosho GO; Sowunmi A; Zalis MG; Oduola AM; Happi CT
    Acta Trop; 2011 Dec; 120(3):224-30. PubMed ID: 21920347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
    Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.
    Andriantsoanirina V; Ménard D; Rabearimanana S; Hubert V; Bouchier C; Tichit M; Bras JL; Durand R
    Am J Trop Med Hyg; 2010 May; 82(5):782-7. PubMed ID: 20439955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border.
    Phompradit P; Wisedpanichkij R; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2011; 120(1-2):130-5. PubMed ID: 21777558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.
    Henry M; Briolant S; Zettor A; Pelleau S; Baragatti M; Baret E; Mosnier J; Amalvict R; Fusai T; Rogier C; Pradines B
    Antimicrob Agents Chemother; 2009 May; 53(5):1926-30. PubMed ID: 19273668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia.
    Pradines B; Bertaux L; Pomares C; Delaunay P; Marty P
    Malar J; 2011 Sep; 10():268. PubMed ID: 21923936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes.
    Bustamante C; Folarin OA; Gbotosho GO; Batista CN; Mesquita EA; Brindeiro RM; Tanuri A; Struchiner CJ; Sowunmi A; Oduola A; Wirth DF; Zalis MG; Happi CT
    J Infect Dis; 2012 Aug; 206(3):324-32. PubMed ID: 22615315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.
    Meng H; Zhang R; Yang H; Fan Q; Su X; Miao J; Cui L; Yang Z
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4306-13. PubMed ID: 20643902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro sensitivity to antimalarial drugs and polymorphisms in Pfg377 gene in Plasmodium falciparum field isolates from Mewat, India.
    Singh V; Kumar A; Gupta P
    Pathog Glob Health; 2017 Jul; 111(5):225-233. PubMed ID: 28605993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
    Fall B; Pascual A; Sarr FD; Wurtz N; Richard V; Baret E; Diémé Y; Briolant S; Bercion R; Wade B; Tall A; Pradines B
    Malar J; 2013 Mar; 12():107. PubMed ID: 23510258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R; Tan-Ariya P; Mungthin M
    Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.
    Chaorattanakawee S; Lanteri CA; Sundrakes S; Yingyuen K; Gosi P; Chanarat N; Wongarunkochakorn S; Buathong N; Chann S; Kuntawunginn W; Arsanok M; Lin JT; Juliano JJ; Tyner SD; Char M; Lon C; Saunders DL
    Malar J; 2015 Dec; 14():486. PubMed ID: 26626127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
    Mwai L; Kiara SM; Abdirahman A; Pole L; Rippert A; Diriye A; Bull P; Marsh K; Borrmann S; Nzila A
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5069-73. PubMed ID: 19770282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.